I was laid off in December, after 10 years of working at the same company. I had accumulated some money in my 401k there, and rolled it over into a rollover IRA. My mom (the family investment maven with a proven track record) has been advising me on what to buy. I asked her to check out Osiris for me, as I have been following the company's Crohn's Disease treatment trials for the stem cell product Prochymal. When I read that Osiris had sold large amounts of Prochymal to the US Department of Defense for possible future use in case of a radiation emergency, I was intrigued. That is an acutal sale, right? My brain's wheels started clicking.
Although it may be years before a new Crohn's Disease pahse III trial is completed and the drug approved, I still think that they may have something there. Considering that the trials were scrapped because TOO MANY of the participants felt better, that is sure better than bad side effects, or it not working at all. (Unfortunatelly almost all of the study participants reported feeling better - even the ones on the placebo. They may have been effected by knowing that if they were on the drug and were doing better they would have a chance to continue taking it) Also since Crohn's has a emotional component to it, they may have also had a feeling of elation at being part of the study and that may have made their symtoms get better for a time. Anyone with Crohn's can tell you its an up and down situation.
Anyway, I bought just a little bit of Osiris, at about 12.15 a share earlier today. I am a little bit excited and now I will be following them for the site as well as for myself.
I will still report negative as well as positive news about them. By the way, there is a legal firl trying to investigate them for investor fraud due to the mishandling of the research trial. (KaplanFox) Seems kind of iffy to me, I don't think the company screwed up on purpose. Not really in their best interests to do that. The science of the study has to be clean. If it was not set up properly, it has to be redone. That is that.
Stock Information
|
OSIR - (NASDAQ)
$12.15 - 0.17 |
